Ülke: İrlanda
Dil: İngilizce
Kaynak: HPRA (Health Products Regulatory Authority)
A/Victoria/4897/2022 (H1N1)pdm09-like strain (A/Victoria/4897/2022, IVR-238; A/Darwin/9/2021 (H3N2) - like strain (A/Darwin/9/2021, IVR-228); B/Austria/1359417/2021 - like strain (B/Michigan/01/2021, wild type); B/PHUKET/3073/2013 -LIKE STRAIN (B/PHUKET/3073/2013, WILD TYPE)
Sanofi Pasteur
J07BB; J07BB02
A/Victoria/4897/2022 (H1N1)pdm09-like strain (A/Victoria/4897/2022, IVR-238; A/Darwin/9/2021 (H3N2) - like strain (A/Darwin/9/2021, IVR-228); B/Austria/1359417/2021 - like strain (B/Michigan/01/2021, wild type); B/PHUKET/3073/2013 -LIKE STRAIN (B/PHUKET/3073/2013, WILD TYPE)
15 microgram(s)
Suspension for injection in pre-filled syringe
Product subject to prescription which may not be renewed (A)
Influenza vaccines; influenza, inactivated, split virus or surface antigen
Marketed
2016-07-15
PACKAGE LEAFLET: INFORMATION FOR THE USER QUADRIVALENT INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED), SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE Quadrivalent influenza vaccine (split virion, inactivated) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU OR YOUR CHILD ARE VACCINATED BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor, pharmacist or nurse. - This vaccine has been prescribed for you or your child only. Do not pass it on to others. - If you or your child get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See Section 4. WHAT IS IN THIS LEAFLET 1. What Quadrivalent Influenza Vaccine (split virion, inactivated) is and what it is used for 2. What you need to know before you or your child use Quadrivalent Influenza Vaccine (split virion, inactivated) 3. How to use Quadrivalent Influenza Vaccine (split virion, inactivated) 4. Possible side effects 5. How to store Quadrivalent Influenza Vaccine (split virion, inactivated) 6. Contents of the pack and other information 1. WHAT QUADRIVALENT INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED) IS AND WHAT IT IS USED FOR Quadrivalent Influenza Vaccine (split virion, inactivated) is a vaccine. This vaccine administered to you or your child from 6 months of age helps to protect you or your child against influenza (flu). When a person is given Quadrivalent Influenza Vaccine (split virion, inactivated), the immune system (the body’s natural defence system) will produce its own protection (antibodies) against the disease. When given during pregnancy the vaccine helps to protect the pregnant women but also helps to protect her baby from birth to less than 6 months of age through the transmission of protection from mother to baby during pregnancy (see also Sections 2 and 3). None of the ingredients in the vaccine can cause flu. The use of Quadrivalent Influenza Vaccine (split virion, inactiva Belgenin tamamını okuyun
Health Products Regulatory Authority 22 August 2023 CRN00DM8T Page 1 of 15 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Quadrivalent Influenza Vaccine (split virion, inactivated), suspension for injection in pre-filled syringe Quadrivalent influenza vaccine (split virion, inactivated) 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Influenza virus (inactivated, split) of the following strains*: A/Victoria/4897/2022 (H1N1) pdm09- like strain (A/Victoria/4897/2022, IVR-238)…………………........................... 15 micrograms HA** A/Darwin/9/2021 (H3N2) - like strain (A/Darwin/9/2021, IVR-228)……………………………………......................….................15 micrograms HA** B/Austria/1359417/2021 - like strain (B/Michigan/01/2021, wild type).…..….......................................................................15 micrograms HA B/Phuket/3073/2013 - like strain (B/Phuket/3073/2013, wild type)....................... 15 micrograms HA** Per 0.5 mL dose * propagated in fertilised hens' eggs from healthy chicken flocks ** haemagglutinin This vaccine complies with the WHO recommendations (Northern Hemisphere) and EU decision for the 2021/2022 season. For the full list of excipients, see Section 6.1. Quadrivalent Influenza Vaccine (split virion, inactivated) may contain traces of eggs, such as ovalbumin, and of neomycin, formaldehyde and octoxinol-9, which are used during the manufacturing process (see Section 4.3). 3 PHARMACEUTICAL FORM Suspension for injection in pre-filled syringe. The vaccine, after shaking gently, is a colourless opalescent liquid. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Quadrivalent Influenza Vaccine (split virion, inactivated) is indicated for the prevention of influenza disease caused by the two influenza A virus subtypes and the two influenza B virus types contained in the vaccine for: active immunisation of adults, including pregnant women, and children from 6 months of age and older, passive protection of infant(s) from bir Belgenin tamamını okuyun